Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
77.98 (1y: +32%)
Market Cap 3.26 B P/E(ttm) 26.80
Enterprise Value 3.92 B P/B 1.80
TFX- NYSE (USA)
Teleflex Inc.
  • Currently 1/5
Business Predictability Rank: 1-Star
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$77.98
Switch to:

GuruFocus Financial Strength Rank measures how strong a companyย’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry		 vs
history
Cash to Debt 0.347
TFX's Cash to Debt is ranked lower than
72% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3750.67 vs. TFX: 0.347 )
TFX' s 10-Year Cash to Debt Range
Min: 0.07   Max: 0.61
Current: 0.35
0.07
0.61
Equity to Asset -0.142
TFX's Equity to Asset is ranked lower than
93% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 0.53 vs. TFX: -0.142 )
TFX' s 10-Year Equity to Asset Range
Min: -0.34   Max: 0.37
Current: -0.14
-0.34
0.37
F-Score: 7
Z-Score: 1.79
M-Score: -2.51
GuruFocus Profitability Rank ranks how profitable a company is and how likely the companyย’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
ย•ย•3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rankย•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry		 vs
history
Operating margin (%) -6.30
TFX's Operating margin (%) is ranked higher than
75% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 5.80 vs. TFX: -6.30 )
TFX' s 10-Year Operating margin (%) Range
Min: -6.3   Max: 92.2
Current: -6.3
-6.3
92.2
Net-margin (%) -12.3
TFX's Net-margin (%) is ranked higher than
66% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3.25 vs. TFX: -12.3 )
TFX' s 10-Year Net-margin (%) Range
Min: -12.3   Max: 21.1
Current: -12.3
-12.3
21.1
ROE (%) -10.7
TFX's ROE (%) is ranked higher than
58% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 4.80 vs. TFX: -10.7 )
TFX' s 10-Year ROE (%) Range
Min: -10.7   Max: 19.2
Current: -10.7
-10.7
19.2
ROA (%) -5.1
TFX's ROA (%) is ranked higher than
52% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3.40 vs. TFX: -5.1 )
TFX' s 10-Year ROA (%) Range
Min: -5.1   Max: 8.2
Current: -5.1
-5.1
8.2
ROC (Joel Greenblatt) (%) -12.80
TFX's ROC (Joel Greenblatt) (%) is ranked higher than
75% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 14.00 vs. TFX: -12.80 )
TFX' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -12.8   Max: 171
Current: -12.8
-12.8
171
Revenue Growth (%) -5.4
TFX's Revenue Growth (%) is ranked higher than
52% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. TFX: -5.4 )
TFX' s 10-Year Revenue Growth (%) Range
Min: -11.4   Max: 6.1
Current: -5.4
-11.4
6.1
ยป TFX's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades
Q2 2012

TFX Guru Trades in Q2 2012

Paul Tudor Jones 5,900 sh (+5.36%)
Third Avenue Management 858,476 sh (+4.86%)
Robert Olstein 144,000 sh (+0.7%)
David Dreman 569,258 sh (+0.27%)
Murray Stahl 7,801 sh (unchged)
Chuck Royce 369,700 sh (unchged)
» More
Q3 2012

TFX Guru Trades in Q3 2012

John Keeley 33,250 sh (New)
Steven Cohen 70,701 sh (New)
Jim Simons 19,000 sh (New)
Murray Stahl 7,801 sh (unchged)
Chuck Royce 369,700 sh (unchged)
Paul Tudor Jones Sold Out
David Dreman 556,384 sh (-2.26%)
Third Avenue Management 794,472 sh (-7.46%)
Robert Olstein 128,000 sh (-11.11%)
» More
Q4 2012

TFX Guru Trades in Q4 2012

Paul Tudor Jones 6,800 sh (New)
Steven Cohen 109,657 sh (+55.1%)
Jim Simons 22,200 sh (+16.84%)
Third Avenue Management 806,972 sh (+1.57%)
John Keeley 33,390 sh (+0.42%)
Chuck Royce 369,700 sh (unchged)
Murray Stahl 7,801 sh (unchged)
Robert Olstein 125,000 sh (-2.34%)
David Dreman 454,199 sh (-18.37%)
» More
Q1 2013

TFX Guru Trades in Q1 2013

Jim Simons 146,800 sh (+561.26%)
John Keeley 34,190 sh (+2.4%)
Chuck Royce 369,700 sh (unchged)
Steven Cohen 106,644 sh (-2.75%)
Third Avenue Management 767,974 sh (-4.83%)
Murray Stahl 7,201 sh (-7.69%)
Robert Olstein 94,000 sh (-24.8%)
Paul Tudor Jones 3,800 sh (-44.12%)
David Dreman 41,925 sh (-90.77%)
» More
» Details

Insider Trades

Latest Guru Trades with TFX

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
David Dreman 2013-03-31 Reduce -90.77%0.84%$71.31 - $84.51 $ 77.981%41925
John Keeley 2012-09-30 New Buy0.05%$60.55 - $70.62 $ 77.9821%33250
Joel Greenblatt 2012-03-31 Sold Out 0.08%$58.01 - $63.56 $ 77.9837%0
Joel Greenblatt 2011-09-30 Reduce -64.36%0.15%$49.51 - $63.14 $ 77.9837%9888
Joel Greenblatt 2011-06-30 Add 140.23%0.14%$57.82 - $63.81 $ 77.9828%27742
Joel Greenblatt 2011-03-31 Add 58.24%0.07%$53.81 - $61.36 $ 77.9836%11548
Mario Gabelli 2011-03-31 Sold Out $53.81 - $61.36 $ 77.9836%0
David Dreman 2010-12-31 Add 20.46%0.13%$49.94 - $58.36 $ 77.9842%697813
Joel Greenblatt 2010-12-31 New Buy0.13%$49.94 - $58.36 $ 77.9842%7298
David Dreman 2010-09-30 Add 15.96%0.1%$48.06 - $58.82 $ 77.9846%579295
Mario Gabelli 2010-09-30 New Buy$48.06 - $58.82 $ 77.9846%16082
Mario Gabelli 2010-06-30 Sold Out $53.7 - $66.02 $ 77.9831%0
Premium More recent guru trades are included for Premium Members only!!

Ratios

vs
industry		 vs
history
P/E(ttm) 26.80
TFX's P/E(ttm) is ranked higher than
92% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 24.10 vs. TFX: 26.80 )
TFX' s 10-Year P/E(ttm) Range
Min: 4.99   Max: 236.09
Current: 26.8
4.99
236.09
P/B 1.80
TFX's P/B is ranked higher than
56% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 1.99 vs. TFX: 1.80 )
TFX' s 10-Year P/B Range
Min: 1.05   Max: 2.87
Current: 1.8
1.05
2.87
P/S 2.05
TFX's P/S is ranked lower than
53% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 1.70 vs. TFX: 2.05 )
TFX' s 10-Year P/S Range
Min: 0.66   Max: 2.25
Current: 2.05
0.66
2.25
PFCF 31.57
TFX's PFCF is ranked lower than
61% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 18.60 vs. TFX: 31.57 )
TFX' s 10-Year PFCF Range
Min: 5.89   Max: 54.81
Current: 31.57
5.89
54.81
EV-to-EBIT 17.64
TFX's EV-to-EBIT is ranked higher than
77% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 16.25 vs. TFX: 17.64 )
TFX' s 10-Year EV-to-EBIT Range
Min: 1   Max: 20.8
Current: 17.64
1
20.8
Shiller P/E 19.61
TFX's Shiller P/E is ranked higher than
95% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 23.60 vs. TFX: 19.61 )
TFX' s 10-Year Shiller P/E Range
Min: 10.37   Max: 27.24
Current: 19.61
10.37
27.24

Dividend & Buy Back

vs
industry		 vs
history
Dividend Yield 1.74
TFX's Dividend Yield is ranked higher than
82% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 1.71 vs. TFX: 1.74 )
TFX' s 10-Year Dividend Yield Range
Min: 1.17   Max: 3.48
Current: 1.74
1.17
3.48
Yield on cost (5-Year) 1.73
TFX's Yield on cost (5-Year) is ranked higher than
82% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 1.76 vs. TFX: 1.73 )
TFX' s 10-Year Yield on cost (5-Year) Range
Min: 1.19   Max: 3.53
Current: 1.73
1.19
3.53
Share Buyback Rate -0.6
TFX's Share Buyback Rate is ranked higher than
81% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: -1.05 vs. TFX: -0.6 )
TFX' s 10-Year Share Buyback Rate Range
Min: 0.8   Max: -0.9
Current: -0.6

Valuation & Return

vs
industry		 vs
history
Price/Net Current Asset Value 9.2
TFX's Price/Net Current Asset Value is ranked higher than
72% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 8.90 vs. TFX: 9.2 )
TFX' s 10-Year Price/Net Current Asset Value Range
Min: 3.5   Max: 8.4
Current: 9.2
3.5
8.4
Price/DCF (Projected) 1.1
TFX's Price/DCF (Projected) is ranked higher than
78% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 1.25 vs. TFX: 1.1 )
TFX' s 10-Year Price/DCF (Projected) Range
Min: 0.6   Max: 1.1
Current: 1.1
0.6
1.1
Price/Median PS Value 2.1
TFX's Price/Median PS Value is ranked higher than
94% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 0.80 vs. TFX: 2.1 )
TFX' s 10-Year Price/Median PS Value Range
Min: 0.8   Max: 1.9
Current: 2.1
0.8
1.9
Earnings Yield (Greenblatt) 5.70
TFX's Earnings Yield (Greenblatt) is ranked higher than
85% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 5.95 vs. TFX: 5.70 )
TFX' s 10-Year Earnings Yield (Greenblatt) Range
Min: 4.8   Max: 104.4
Current: 5.7
4.8
104.4
Forward Rate of Return (Yacktman) 4.38
TFX's Forward Rate of Return (Yacktman) is ranked higher than
70% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3.03 vs. TFX: 4.38 )
TFX' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -20.3   Max: 46.4
Current: 4.38
-20.3
46.4

Business Description

Teleflex Inc. is a Delaware Corporation incorporated in 1943. The Company is a global provider of medical technology products that enhance clinical benefits, improve patient and provider safety and reduce total procedural costs. To achieve this mission, Teleflex is committed to the following: investing in technology and developing its pipeline; leveraging and building its core franchises and distribution channels; attracting, developing and retaining talented employees around the world; and continuing to build financial strength by expanding its margins and maintaining strong cash flow all in an effort to successfully grow its reputation as a solid investment and a profitable, strong employer. It primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It sells its products to hospitals and healthcare providers in more than 130 countries through a combination of its direct sales force and distributors. The Company's products are used in a wide variety of markets and are not dependent upon any one end-market or procedure. Teleflex is entirely focused on healthcare and operates as a diversified, global medical technology company. It provides a broad-based platform of products, which it categorizes into four groups: Critical Care, Surgical Care, Cardiac Care and OEM and Development Services. It is a provider of specialty products for critical care, which is predominantly comprised of single-use products. The large majority of sales for single-use products are made to the hospital/healthcare provider market, with a smaller percentage sold to alternate sites. The Company's surgical products include: ligation and closure products, including appliers, clips and sutures used in a variety of surgical procedures; access ports used in minimally invasive surgical procedures, including robotic surgery; and fluid management products used for chest drainage. The Company's surgical products also include hand-held instruments for general and specialty surgical procedures. It markets surgical products under the Deknatel, Pleur-evac, Pilling, Taut and Weck brand names. Products in Cardiac Care category include diagnostic catheters and capital equipment. The Company's diagnostic catheters include thermodilution and wedge pressure catheters; specialized angiographic catheters, such as Berman and Reverse Berman catheters; therapeutic delivery catheters, such as temporary pacing catheters; sheaths for femoral and trans-radial aortic access used in diagnostic and therapeutic procedures; and intra-aortic balloon, or IAB, catheters. Capital equipment includes its intra-aortic balloon pump, or IABP, consoles. IABP products are used to augment oxygen delivery to the cardiac muscle and reduce the oxygen demand after cardiac surgery, serious heart attack or interventional procedures. The IAB and IABP
Company Website
SEC Reports
Industry: Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ
Traded in other countries:TBH.Germany
ยป More Articles for TFX

Headlines

Articles On GuruFocus.com
Teleflex Incorporated: Successful Transition into Pure-Play Medical Device Manufacturer Nov 19 2012 
5 Healthcare Stocks You Should Know About Mar 31 2012 
Teleflex: High Upside Potential This Year Mar 27 2012 
5 Healthcare Stocks to Consider for 2012 Mar 27 2012 
Third Avenue Management Buys Lowes, Teleflex, American Eagle Outfitters, Tellabs, Sells Pharmaceutic Nov 17 2011 
Teleflex Inc. Reports Operating Results (10-Q) Oct 27 2010 
Teleflex Inc. Reports Operating Results (10-Q) Jul 23 2010 
Teleflex Inc. Reports Operating Results (10-Q) Apr 28 2010 
Weekly CFO Buys Highlight: UGI Corp., FelCor Lodging Trust, Altair Nanotechnologies, TICC Capital, C Mar 28 2010 
Teleflex Inc. (TFX) CFO Richard A Meier buys 5,000 Shares Mar 22 2010 

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial